Intra-Cellular Therapies Inc (ITCI)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: ITCI Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-06 2024-12-05 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
1,534 -0.1%
84.69
USD 129,914 		1,534 -0.1% 84.69 USD 129,914
2024-12-06 2024-12-05 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
50,163 -4.5%
84.06
USD 4,216,928 		50,163 -4.5% 84.06 USD 4,216,928
2024-12-06 2024-12-04 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
23,333 -2.1%
86.00
USD 2,006,750 		23,333 -2.1% 86.00 USD 2,006,750
2024-12-06 2024-12-04 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
27,667 -2.5%
85.62
USD 2,368,909 		27,667 -2.5% 85.62 USD 2,368,909
2024-11-14 2024-11-13 PS Planned sale

Halstead Michael

President

Officer
5,343 -100.0%
88.92
USD 475,100 		5,343 -100.0% 88.92 USD 475,100
2024-11-14 2024-11-13 PS Planned sale

Halstead Michael

President

Officer
13,371 -71.4%
88.17
USD 1,178,921 		13,371 -71.4% 88.17 USD 1,178,921
2024-11-14 2024-11-12 PS Planned sale

Halstead Michael

President

Officer
1,648 -100.0%
90.89
USD 149,787 		1,648 -100.0% 90.89 USD 149,787
2024-11-14 2024-11-12 PS Planned sale

Halstead Michael

President

Officer
6,116 -78.8%
89.63
USD 548,177 		6,116 -78.8% 89.63 USD 548,177
2024-11-14 2024-11-12 PS Planned sale

Halstead Michael

President

Officer
15,105 -66.1%
88.72
USD 1,340,116 		15,105 -66.1% 88.72 USD 1,340,116
2024-08-30 2024-08-30 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
6,193 -0.6%
73.32
USD 454,091 		6,193 -0.6% 73.32 USD 454,091
2024-08-30 2024-08-30 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
28,203 -2.6%
72.73
USD 2,051,261 		28,203 -2.6% 72.73 USD 2,051,261
2024-08-30 2024-08-29 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
5,772 -0.5%
73.25
USD 422,771 		5,772 -0.5% 73.25 USD 422,771
2024-08-30 2024-08-29 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
29,832 -2.7%
72.44
USD 2,161,114 		29,832 -2.7% 72.44 USD 2,161,114
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
240 -0.0%
73.70
USD 17,688 		240 -0.0% 73.70 USD 17,688
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
240 -0.0%
73.70
USD 17,688 		240 -0.0% 73.70 USD 17,688
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
32,459 -2.9%
72.74
USD 2,361,113 		32,459 -2.9% 72.74 USD 2,361,113
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
32,459 -2.9%
72.74
USD 2,361,113 		32,459 -2.9% 72.74 USD 2,361,113
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
16,856 -1.6%
73.93
USD 1,246,191 		16,856 -1.6% 73.93 USD 1,246,191
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
16,856 -1.6%
73.93
USD 1,246,191 		16,856 -1.6% 73.93 USD 1,246,191
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
23,657 -2.1%
73.33
USD 1,734,865 		23,657 -2.1% 73.33 USD 1,734,865
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
23,657 -2.1%
73.33
USD 1,734,865 		23,657 -2.1% 73.33 USD 1,734,865
2024-08-28 2024-08-26 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
22,713 -2.1%
74.59
USD 1,694,229 		22,713 -2.1% 74.59 USD 1,694,229
2024-08-28 2024-08-26 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
22,713 -2.1%
74.59
USD 1,694,229 		22,713 -2.1% 74.59 USD 1,694,229
2024-08-23 2024-08-23 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
28,680 -2.6%
74.46
USD 2,135,435 		28,680 -2.6% 74.46 USD 2,135,435
2024-08-23 2024-08-22 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
4,369 -0.4%
75.47
USD 329,727 		4,369 -0.4% 75.47 USD 329,727
2024-08-23 2024-08-22 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
35,011 -3.2%
74.58
USD 2,611,075 		35,011 -3.2% 74.58 USD 2,611,075
2024-08-23 2024-08-21 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
1,900 -0.2%
77.98
USD 148,163 		1,900 -0.2% 77.98 USD 148,163
2024-08-23 2024-08-21 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
2,682 -0.2%
77.21
USD 207,088 		2,682 -0.2% 77.21 USD 207,088
2024-08-23 2024-08-21 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
4,297 -0.4%
76.20
USD 327,432 		4,297 -0.4% 76.20 USD 327,432
2024-08-23 2024-08-21 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
44,134 -3.9%
75.40
USD 3,327,818 		44,134 -3.9% 75.40 USD 3,327,818
2024-08-20 2024-08-16 S Sale

Neumann Mark

EVP, Chief Commercial Officer

Officer
18,714 -38.7%
75.08
USD 1,405,047 		18,714 -38.7% 75.08 USD 1,405,047
2024-06-25 2024-06-24 S Sale

RIGGS RORY B

Non-Executive Director
4,462 -3.7%
75.57
USD 337,193 		4,462 -3.7% 75.57 USD 337,193
2024-06-21 2024-06-18 PS Planned sale

VAN NOSTRAND ROBERT L

Non-Executive Director
11,109 -53.4%
76.07
USD 845,062 		11,109 -53.4% 76.07 USD 845,062
2024-06-21 2024-06-18 PS Planned sale

VAN NOSTRAND ROBERT L

Non-Executive Director
8,891 -29.9%
75.71
USD 673,138 		8,891 -29.9% 75.71 USD 673,138
2024-03-11 2024-03-11 PS Planned sale

Durgam Suresh K.

EVP, Chief Medical Officer

Officer
661 -3.2%
66.96
USD 44,261 		661 -3.2% 66.96 USD 44,261
2024-03-11 2024-03-11 PS Planned sale

Durgam Suresh K.

EVP, Chief Medical Officer

Officer
872 -4.1%
65.89
USD 57,456 		872 -4.1% 65.89 USD 57,456
2024-03-11 2024-03-11 PS Planned sale

Durgam Suresh K.

EVP, Chief Medical Officer

Officer
2,179 -9.3%
65.06
USD 141,766 		2,179 -9.3% 65.06 USD 141,766
2024-03-11 2024-03-11 PS Planned sale

Neumann Mark

EVP, Chief Commercial Officer

Officer
1,313 -4.2%
66.86
USD 87,787 		1,313 -4.2% 66.86 USD 87,787
2024-03-11 2024-03-11 PS Planned sale

Neumann Mark

EVP, Chief Commercial Officer

Officer
1,729 -5.3%
65.92
USD 113,976 		1,729 -5.3% 65.92 USD 113,976
2024-03-11 2024-03-11 PS Planned sale

Neumann Mark

EVP, Chief Commercial Officer

Officer
4,303 -11.6%
65.11
USD 280,168 		4,303 -11.6% 65.11 USD 280,168
2024-03-11 2024-03-11 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
306 -0.0%
67.33
USD 20,603 		306 -0.0% 67.33 USD 20,603
2024-03-11 2024-03-11 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
1,590 -0.2%
66.81
USD 106,228 		1,590 -0.2% 66.81 USD 106,228
2024-03-11 2024-03-11 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
4,128 -0.4%
65.90
USD 272,035 		4,128 -0.4% 65.90 USD 272,035
2024-03-11 2024-03-11 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
14,541 -1.4%
64.80
USD 942,257 		14,541 -1.4% 64.80 USD 942,257
2024-03-11 2024-03-11 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
64 -100.0%
67.12
USD 4,296 		64 -100.0% 67.12 USD 4,296
2024-03-11 2024-03-11 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
4,475 -98.6%
66.47
USD 297,453 		4,475 -98.6% 66.47 USD 297,453
2024-03-11 2024-03-11 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
29 -100.0%
67.32
USD 1,952 		29 -100.0% 67.32 USD 1,952
2024-03-11 2024-03-11 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
1,100 -97.4%
66.54
USD 73,194 		1,100 -97.4% 66.54 USD 73,194
2024-03-11 2024-03-11 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
4,453 -79.8%
65.28
USD 290,692 		4,453 -79.8% 65.28 USD 290,692
2024-03-11 2024-03-11 PS Planned sale

Halstead Michael

EVP and General Counsel

Officer
1,238 -100.0%
66.70
USD 82,575 		1,238 -100.0% 66.70 USD 82,575
2024-03-11 2024-03-11 PS Planned sale

Halstead Michael

EVP and General Counsel

Officer
6,107 -83.1%
65.82
USD 401,963 		6,107 -83.1% 65.82 USD 401,963
2024-03-11 2024-03-07 PS Planned sale

Durgam Suresh K.

EVP, Chief Medical Officer

Officer
2,722 -14.4%
66.86
USD 181,993 		2,722 -14.4% 66.86 USD 181,993
2024-03-11 2024-03-07 PS Planned sale

Durgam Suresh K.

EVP, Chief Medical Officer

Officer
3,728 -16.5%
66.34
USD 247,316 		3,728 -16.5% 66.34 USD 247,316
2024-03-11 2024-03-07 PS Planned sale

Neumann Mark

EVP, Chief Commercial Officer

Officer
4,496 -13.1%
66.95
USD 301,007 		4,496 -13.1% 66.95 USD 301,007
2024-03-11 2024-03-07 PS Planned sale

Neumann Mark

EVP, Chief Commercial Officer

Officer
8,636 -20.2%
66.37
USD 573,171 		8,636 -20.2% 66.37 USD 573,171
2024-03-11 2024-03-07 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
8,754 -0.8%
66.93
USD 585,905 		8,754 -0.8% 66.93 USD 585,905
2024-03-11 2024-03-07 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
31,958 -2.9%
66.38
USD 2,121,372 		31,958 -2.9% 66.38 USD 2,121,372
2024-03-11 2024-03-07 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
6,618 -100.0%
66.93
USD 442,943 		6,618 -100.0% 66.93 USD 442,943
2024-03-11 2024-03-07 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
6,514 -49.6%
66.26
USD 431,618 		6,514 -49.6% 66.26 USD 431,618
2024-03-11 2024-03-07 PS Planned sale

Halstead Michael

EVP and General Counsel

Officer
220 -100.0%
66.81
USD 14,698 		220 -100.0% 66.81 USD 14,698
2024-03-11 2024-03-07 PS Planned sale

Halstead Michael

EVP and General Counsel

Officer
12,912 -98.3%
66.14
USD 854,000 		12,912 -98.3% 66.14 USD 854,000
2024-02-28 2024-02-27 S Sale

VAN NOSTRAND ROBERT L

Non-Executive Director
10,349 -51.8%
73.14
USD 756,926 		10,349 -51.8% 73.14 USD 756,926
2024-02-28 2024-02-27 S Sale

VAN NOSTRAND ROBERT L

Non-Executive Director
9,651 -32.6%
72.71
USD 701,724 		9,651 -32.6% 72.71 USD 701,724
2024-02-27 2024-02-26 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
600 -100.0%
69.81
USD 41,886 		600 -100.0% 69.81 USD 41,886
2024-02-27 2024-02-26 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
5,282 -89.8%
69.47
USD 366,941 		5,282 -89.8% 69.47 USD 366,941
2024-02-27 2024-02-26 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
288 -100.0%
70.15
USD 20,203 		288 -100.0% 70.15 USD 20,203
2024-02-27 2024-02-26 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
6,867 -96.0%
69.38
USD 476,432 		6,867 -96.0% 69.38 USD 476,432
2024-02-27 2024-02-26 PS Planned sale

Hineline Lawrence J.

SVP of Finance, CFO

Officer
300 -4.0%
68.33
USD 20,499 		300 -4.0% 68.33 USD 20,499
2024-02-27 2024-02-26 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
12,462 -1.2%
70.11
USD 873,711 		12,462 -1.2% 70.11 USD 873,711
2024-02-27 2024-02-26 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
9,528 -0.9%
69.45
USD 661,720 		9,528 -0.9% 69.45 USD 661,720
2024-02-27 2024-02-26 PS Planned sale

Mates Sharon

Chairman, President & CEO

Executive Director
600 -0.1%
68.39
USD 41,034 		600 -0.1% 68.39 USD 41,034
2024-02-27 2024-02-26 S Sale

MARCUS JOEL S

Non-Executive Director
299 -0.7%
69.60
USD 20,810 		299 -0.7% 69.60 USD 20,810
2024-02-27 2024-02-26 S Sale

MARCUS JOEL S

Non-Executive Director
17,658 -30.6%
69.07
USD 1,219,638 		17,658 -30.6% 69.07 USD 1,219,638
2024-02-27 2024-02-26 S Sale

MARCUS JOEL S

Non-Executive Director
8,371 -12.7%
67.83
USD 567,805 		8,371 -12.7% 67.83 USD 567,805
2024-02-27 2024-02-26 PS Planned sale

Durgam Suresh K.

EVP, Chief Medical Officer

Officer
1,312 -12.1%
71.02
USD 93,178 		1,312 -12.1% 71.02 USD 93,178
// ... existing code ... // ... rest of the file ...